152 related articles for article (PubMed ID: 22734706)
1. Modeling anti-HIV compounds: the role of analogue-based approaches.
Srivastava HK; Bohari MH; Sastry GN
Curr Comput Aided Drug Des; 2012 Sep; 8(3):224-48. PubMed ID: 22734706
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR and docking studies on the HEPT derivatives of HIV-1 reverse transcriptase.
Latha RS; Vijayaraj R; Singam ER; Chitra K; Subramanian V
Chem Biol Drug Des; 2011 Sep; 78(3):418-26. PubMed ID: 21689378
[TBL] [Abstract][Full Text] [Related]
3. Revealing the drug-resistant mechanism for diarylpyrimidine analogue inhibitors of HIV-1 reverse transcriptase.
Zhang H; Qin F; Ye W; Li Z; Ma S; Xia Y; Jiang Y; Zhu J; Li Y; Zhang J; Chen HF
Chem Biol Drug Des; 2011 Sep; 78(3):427-37. PubMed ID: 21696545
[TBL] [Abstract][Full Text] [Related]
4. QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method.
Toropova AP; Toropov AA; Veselinović JB; Miljković FN; Veselinović AM
Eur J Med Chem; 2014 Apr; 77():298-305. PubMed ID: 24657566
[TBL] [Abstract][Full Text] [Related]
5. Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads.
Vadivelan S; Deeksha TN; Arun S; Machiraju PK; Gundla R; Sinha BN; Jagarlapudi SA
Eur J Med Chem; 2011 Mar; 46(3):851-9. PubMed ID: 21272964
[TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA.
Xu HR; Fu L; Zhan P; Liu XY
SAR QSAR Environ Res; 2016 Dec; 27(12):999-1014. PubMed ID: 27667445
[TBL] [Abstract][Full Text] [Related]
7. Hologram quantitative structure-activity relationships investigations of non-nucleoside reverse transcriptase inhibitors.
Pungpo P; Hannongbua S; Wolschann P
Curr Med Chem; 2003 Sep; 10(17):1661-77. PubMed ID: 12871115
[TBL] [Abstract][Full Text] [Related]
8. Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives.
Pungpo P; Saparpakorn P; Wolschann P; Hannongbua S
SAR QSAR Environ Res; 2006 Aug; 17(4):353-70. PubMed ID: 16920659
[TBL] [Abstract][Full Text] [Related]
9. Artificial neural networks: non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors.
Douali L; Villemin D; Zyad A; Cherqaoui D
Mol Divers; 2004; 8(1):1-8. PubMed ID: 14964783
[TBL] [Abstract][Full Text] [Related]
10. Pyrroloaryls and pyrroloheteroaryls: Inhibitors of the HIV fusion/attachment, reverse transcriptase and integrase.
Patel RV; Park SW
Bioorg Med Chem; 2015 Sep; 23(17):5247-63. PubMed ID: 26116177
[TBL] [Abstract][Full Text] [Related]
11. Multi-target QSAR modelling in the analysis and design of HIV-HCV co-inhibitors: an in-silico study.
Liu Q; Zhou H; Liu L; Chen X; Zhu R; Cao Z
BMC Bioinformatics; 2011 Jul; 12():294. PubMed ID: 21774796
[TBL] [Abstract][Full Text] [Related]
12. Comparative QSAR based on neural networks for the anti-HIV activity of HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
Curr Pharm Des; 2003; 9(22):1817-26. PubMed ID: 12871199
[TBL] [Abstract][Full Text] [Related]
13. "In silico" design of potential anti-HIV actives using fragment descriptors.
Varnek A; Solov'ev VP
Comb Chem High Throughput Screen; 2005 Aug; 8(5):403-16. PubMed ID: 16101580
[TBL] [Abstract][Full Text] [Related]
14. Chemical structure and correlation analysis of HIV-1 NNRT and NRT inhibitors and database-curated, published inhibition constants with chemical structure in diverse datasets.
Viira B; García-Sosa AT; Maran U
J Mol Graph Model; 2017 Sep; 76():205-223. PubMed ID: 28738270
[TBL] [Abstract][Full Text] [Related]
15. Anti-HIV activity of HEPT, TIBO, and cyclic urea derivatives: structure-property studies, focused combinatorial library generation, and hits selection using substructural molecular fragments method.
Solov'ev VP; Varnek A
J Chem Inf Comput Sci; 2003; 43(5):1703-19. PubMed ID: 14502505
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Structure-activity Relationship Study of Betulinic Acid Derivatives Against HIV using SMILES-based Descriptors.
Worachartcheewan A; Toropova AP; Toropov AA; Siriwong S; Prapojanasomboon J; Prachayasittikul V; Nantasenamat C
Curr Comput Aided Drug Des; 2018; 14(2):152-159. PubMed ID: 29332601
[TBL] [Abstract][Full Text] [Related]
17. New developments in anti-HIV chemotherapy.
De Clercq E
Biochim Biophys Acta; 2002 Jul; 1587(2-3):258-75. PubMed ID: 12084468
[TBL] [Abstract][Full Text] [Related]
18. QSAR study and VolSurf characterization of anti-HIV quinolone library.
Filipponi E; Cruciani G; Tabarrini O; Cecchetti V; Fravolini A
J Comput Aided Mol Des; 2001 Mar; 15(3):203-17. PubMed ID: 11289075
[TBL] [Abstract][Full Text] [Related]
19. In search of a treatment for HIV--current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Reynolds C; de Koning CB; Pelly SC; van Otterlo WA; Bode ML
Chem Soc Rev; 2012 Jul; 41(13):4657-70. PubMed ID: 22618809
[TBL] [Abstract][Full Text] [Related]
20. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
